187 related articles for article (PubMed ID: 5787285)
21. Treatment of intermittent claudication with inositol nicotinate.
Head A
Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149
[No Abstract] [Full Text] [Related]
22. Digit Ulcerations in a Young Woman.
Varghese B; Chew E; Konig MF
JAMA; 2020 Jul; 324(4):385-386. PubMed ID: 32568390
[No Abstract] [Full Text] [Related]
23. Vasodilator drugs for peripheral vascular disease.
Cook CD
N Engl J Med; 1979 Jul; 301(3):159. PubMed ID: 449958
[No Abstract] [Full Text] [Related]
24. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
Schafé MK
Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
[No Abstract] [Full Text] [Related]
25. Testosterone and fibrinolytic activity.
Winther O
Scand J Clin Lab Invest Suppl; 1967; 99():207-10. PubMed ID: 6060734
[No Abstract] [Full Text] [Related]
26. Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome.
Levy Y; Sherer Y; Shoenfeld Y
Isr Med Assoc J; 2000 Dec; 2(12):960-1. PubMed ID: 11344792
[No Abstract] [Full Text] [Related]
27. Ischemic finger ulcer as a presenting symptom of systemic sclerosis.
Balbir-Gurman A; Markovits D; Nahir AM; Rozin A; Braun-Moscovici Y
Isr Med Assoc J; 2005 Aug; 7(8):531-2. PubMed ID: 16106783
[No Abstract] [Full Text] [Related]
28. [Recommendations of the German Society of Rheumatology on therapy of Raynaud syndrome and acral ulcerations].
Riemekasten G
Z Rheumatol; 2005 Mar; 64(2):90-2. PubMed ID: 15793673
[No Abstract] [Full Text] [Related]
29. [Raynaud syndrome].
Knorr M; Schmid A; steurer J; Vetter W
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):893-6. PubMed ID: 3738337
[No Abstract] [Full Text] [Related]
30. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
Dabizzi RP; Fantini F; Cappelli G; Grandonico F
Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
[No Abstract] [Full Text] [Related]
31. [Clinical study of various vasodilator agents by measuring the isotopic peripheral flow].
Spach MO; Schwartz J
Therapie; 1977; 32(3):301-8. PubMed ID: 337564
[No Abstract] [Full Text] [Related]
32. An evaluation of vasodilator drugs in occlusive vascular disease by measurement.
Gillespie JA
Angiology; 1966 May; 17(5):280-8. PubMed ID: 5936944
[No Abstract] [Full Text] [Related]
33. [Recommendations of the DGRh on the therapy of Raynaud Syndrome (Zeitschrift für Rheumatologie, vol 64, March 2005) ].
Fiehn C
Z Rheumatol; 2005 Sep; 64(6):429. PubMed ID: 16184353
[No Abstract] [Full Text] [Related]
34. The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol).
Haeger K
Vasc Dis; 1968 Dec; 5(4):199-213. PubMed ID: 4177853
[No Abstract] [Full Text] [Related]
35. [Testosterone and the prostate gland].
Winther O
Nord Med; 1970 May; 83(20):624-6. PubMed ID: 5426430
[No Abstract] [Full Text] [Related]
36. Resolution of chronic pain and fingertip ulceration due to hand-arm vibration syndrome following combination pharmacotherapy.
Buell C; Tobinick E; Lamp K
Arch Dermatol; 2007 Oct; 143(10):1343-4. PubMed ID: 17938362
[No Abstract] [Full Text] [Related]
37. [Therapy for Reynaud syndrome].
Riemekasten G
Z Rheumatol; 2006 Feb; 65(1):80. PubMed ID: 16804998
[No Abstract] [Full Text] [Related]
38. Assessment of the efficacy of vasodilator drugs in peripheral vascular disease through a study of skeletal muscle metabolism using 31P nuclear magnetic resonance (NMR) spectroscopy.
Wahl D; Simon JP; Escanye JM; Jouanny P; Robin B; Walker P; Paille F; Schmidt C; Robert J; Schmitt J
Therapie; 1992; 47(2):125-6. PubMed ID: 1412138
[No Abstract] [Full Text] [Related]
39. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
Zanelli G; Ferrero S; Patrone P
Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
[No Abstract] [Full Text] [Related]
40. [Current trends in the drug therapy of primary glaucoma].
Nesterov AP
Vestn Oftalmol; 1967; 80(5):14-20. PubMed ID: 5608391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
